Cost-effectiveness of nivolumab in the treatment of head and neck cancer

Publikation

Cost-effectiveness of nivolumab in the treatment of head and neck cancer

Wissenschaftlicher Artikel/Review - 30.10.2018

Hirschmann A, Lupatsch J E, Schwenkglenks M, Panje Cédric, Matter-Walstra K, Espeli V, Dedes K J, Siano Marco, Swiss Group of Clinical Cancer Research (SAKK)

Hirschmann, A

Lupatsch, J E

Cost-effectiveness of nivolumab in the treatment of head and neck cancer

Hirschmann, A

Lupatsch, J E

Schwenkglenks, M

Panje, Cédric

Matter-Walstra, K

Espeli, V

Dedes, K J

Siano, Marco

Swiss Group of Clinical Cancer Research (SAKK),